2-Amino-5-Chlorothiazole

2-Amino-5-Chlorothiazole


    • Product Name 2-Amino-5-Chlorothiazole
    • Alias 5-Chloro-2-aminothiazole
    • Einecs 219-380-8
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    587544

    Chemical Formula C3H3ClN2S
    Molecular Weight 134.59 g/mol
    Appearance Solid

    As an accredited 2-Amino-5-Chlorothiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 250g of 2 - Amino - 5 - Chlorothiazole packaged in a sealed, chemical - resistant bottle.
    Shipping 2 - Amino - 5 - Chlorothiazole is shipped in properly sealed containers, following strict chemical transport regulations. Packages are carefully labeled. Shipment occurs via approved carriers ensuring safe transit to the destination.
    Storage 2 - Amino - 5 - Chlorothiazole should be stored in a cool, dry, and well - ventilated area. Keep it away from heat sources, flames, and direct sunlight. Store in a tightly closed container to prevent moisture absorption and contact with air, which could potentially lead to degradation. It should be segregated from incompatible substances, such as strong oxidizers and acids.
    Application of 2-Amino-5-Chlorothiazole

    In the convergent synthesis of the HIV‑1 protease inhibitor ritonavir, the thiazole‑5‑methyl fragment is assembled from 2‑amino‑5‑chlorothiazole via a formylation‑reduction pathway. The heterocycle is first subjected to a directed ortho‑metalation using lithium diisopropylamide in anhydrous tetrahydrofuran at –75 °C to –70 °C. Treatment with N,N‑dimethylformamide at this temperature and subsequent acidic work‑up yields 2‑amino‑5‑formylthiazole, which is isolated by extraction into ethyl acetate and crystallized from toluene‑n‑heptane 1:3 v/v. Heavy metal residues are controlled to <20 ppm palladium‑equivalent by a charcoal‑filtration step, a prerequisite for the downstream active pharmaceutical ingredient campaign operating under ICH Q7 guidelines for GMP intermediates. The formyl group is reduced with sodium borohydride in methanol at 0–5 °C, giving the hydroxymethyl derivative, which is then converted to the 5‑(chloromethyl)thiazole with thionyl chloride in dichloromethane in the presence of a catalytic quantity of pyridine. This alkyl halide fragment is condensed with N‑[(N‑methyl‑N‑{[2‑(1‑methylethyl)‑1,3‑thiazol‑4‑yl]methyl}carbamoyl)oxy]‑2‑nitrobenzene‑1‑sulfonamide under phase‑transfer conditions using tetra‑n‑butylammonium bromide in toluene‑water at 50 °C to install the carbamate linkage. On a pilot‑plant scale, the metalation step is run in a 200 L glass‑lined reactor under a nitrogen pad, with the DMF addition triggering an exotherm of 18–22 °C that is managed by jacket cooling. The batch is monitored by in‑process HPLC against a working standard of the formyl compound; typical isolated yield before reduction falls in the narrow band of 72–78%, with a purity exceeding 98.5 area% (detection at 254 nm). Residual solvent levels are validated against USP <467> limits, with THF consistently below 720 ppm in the dried intermediate. The final coupling step is sensitive to moisture; Karl Fischer titration of the toluene phase must read <0.05% water to avoid premature hydrolysis of the chloromethyl ester. Multiple commercial routes to ritonavir fragment 2‑amino‑5‑chlorothiazole intermediates are on file with Drug Master Files filed under US FDA Type II, enabling supply‑chain diversification for second‑source qualification.

    What Controls para‑Chlorine Displacement in Building 2,5‑Functionalized Thiazole Kinase Inhibitors?

    Amination of the 5‑chloro substituent proceeds with high regioselectivity owing to the attenuation of the 2‑amino group’s nucleophilicity—its conjugated acid exhibits a pKa of approximately 5.0—allowing a palladium‑catalyzed Buchwald‑Hartwig coupling to proceed without in situ N‑protection. In the construction of BCR‑ABL tyrosine kinase inhibitor intermediates related to dasatinib, 2‑amino‑5‑chlorothiazole is treated with 1.05 equivalents of 4‑(2‑hydroxyethyl)piperazine in the presence of Pd2(dba)3 (0.02 eq), Xantphos (0.04 eq), and sodium tert‑butoxide (1.4 eq) in degassed toluene at 100 °C for 16–20 h. The oxidative addition at the C‑Cl bond preferentially outcompetes any competing insertion into the C‑H bond at position 4, and the low solubility of the tert‑butoxide base limits the deprotonation of the 2‑amino group, preventing bridging dimer formation. IPC by UPLC‑MS shows > 90% conversion after 12 h, with the major impurity being the debrominated analogue carried through from upstream lot‑to‑lot variation in the starting thiazole. The crude coupling product is extracted into 2 M hydrochloric acid, back‑extracted into methyl tert‑butyl ether at pH 9–10, and crystallized from isopropanol‑water to afford the 5‑piperazinyl‑thiazole intermediate with a purity suitable for subsequent acylation. During process development campaigns, cross‑contamination of the Xantphos ligand with its monoxide form was traced to incomplete inerting during catalyst charge, leading to stalled reactions and elevated palladium residuals in the isolated intermediate—this failure mode is mitigated by sparging the toluene with argon for 45 min before substrate addition. The tolerance of the free 2‑amino group simplifies the route to the thiazole‑5‑carboxamide pharmacophore: a subsequent carboxylation is achieved by metal‑halogen exchange with n‑butyllithium at –78 °C and quenching with carbon dioxide gas, yielding 2‑aminothiazole‑5‑carboxylic acid, which is then coupled with 2‑chloro‑6‑methylaniline via TBTU activation. Residual lithium is removed by aqueous washes to below 50 ppm to comply with ICH Q3D guidelines for elemental impurities (Class 2B metals). The overall convergence of this sequence is evaluated against USP monograph specifications for dasatinib monohydrate, particularly the related substances criterion of ≤0.10% for the 5‑des‑piperazinyl dimer.

    From Sandmeyer Reaction to CCMT: A Two‑Step Chlorofunctionalization Driving Neonicotinoid Supply

    The commercial route to the second‑generation neonicotinoid insecticide clothianidin hinges on the intermediate 2‑chloro‑5‑chloromethyl‑1,3‑thiazole (CCMT, CAS 105827‑91‑6). 2‑Amino‑5‑chlorothiazole is the direct precursor to this building block via a sequential Sandmeyer diazotization‑chlorination. In a continuous‑flow reactor configuration—preferred over batch to contain the diazonium salt accumulation hazard—an aqueous slurry of 2‑amino‑5‑chlorothiazole hydrochloride is fed with sodium nitrite solution (1.02 eq, 40% w/w) into a jacketed spiral tube maintained at 0–3 °C. The diazo stream is immediately introduced into a second flow module containing cuprous chloride dissolved in concentrated hydrochloric acid (molar ratio CuCl:substrate 1.1:1) at 30–35 °C. Residence time in the chlorination zone is controlled at 45–60 s, yielding 2,5‑dichlorothiazole. Phase separation and vacuum distillation (85–88 °C at 50 mbar) deliver the dichlorinated intermediate in 85–88% isolated yield, with the main side‑product being the 5‑unsubstituted thiazole from reductive dediazotization, kept below 3% by strict control of the cuprous halide stoichiometry. The second stage, chloromethylation, is performed by charging 2,5‑dichlorothiazole and paraformaldehyde (1.5 eq) into chlorosulfonic acid at 55–60 °C with vigorous overhead stirring. Gas evolution (HCl and SO3) dictates a scrubbed vent line, and the batch is aged for 8 h before quenching into ice‑water and extracting into dichloromethane. CCMT is purified by fractional distillation; the cut at 108–112 °C (20 mbar) provides material with a GC assay of 99.2% or higher. In multi‑ton campaigns, the chloromethylation exotherm displays a notable induction period of 20–30 min, after which the temperature can spike by 12 °C if not counter‑modulated—a plant‑logged deviation that triggered a process safety review and the installation of a refrigerated brine jacket capable of 25 kW/m3 cooling capacity. CCMT is subsequently condensed with N‑methyl‑N′‑nitroguanidine under alkaline conditions to afford clothianidin technical. Purity requirements for CCMT used in agrochemical synthesis are benchmarked against CIPAC (Collaborative International Pesticides Analytical Council) monograph methods, with particular attention to the removal of potential genotoxic impurities per ICH M7 even though the intermediate is for a non‑pharmaceutical product—a de‑facto standard adopted by toll manufacturers serving EU REACH‑registered supply chains.

    Exhaust Dyeing Microfiber Polyester with Thiazole Disperse Dyes

    2‑Amino‑5‑chlorothiazole serves as the diazo component in a range of high‑tinctorial‑strength monoazo disperse dyes designed for polyethylene terephthalate microfibers (linear density <1.0 dtex). The amine is diazotized in concentrated sulfuric acid‑nitrosylsulfuric acid medium at 0–5 °C because its weak basicity precludes straightforward aqueous diazotization. After a 90 min stir‑out at –2 °C to ensure complete conversion, the diazonium solution is dropped into a coupling tank containing N‑ethyl‑N‑cyanoethyl aniline dissolved in acetic acid‑water with a controlled co‑solvent of sulfamic acid to decompose excess nitrous acid. The coupling pH is maintained between 3.0 and 3.5 by the simultaneous addition of sodium acetate, which buffers the proton activity without precipitating the diazonium salt. The precipitated dye is filtered, washed free of sulfate, and oven‑dried at 70 °C to a moisture content of <0.3%. The resultant chromophore—typically a red to violet shade with λmax in the 520–560 nm range in DMF—is dispersed with lignin sulfonate and nonylphenol‑free dispersing agent in a bead mill until the particle size distribution reaches a D90 of <1.5 µm; milling is run to a PSD specification rather than a fixed time to accommodate lot‑to‑lot crystal hardness variation.

    During application, the commercial dye formulation is applied to PES knitted fabric by high‑temperature exhaust dyeing at 130 °C for 45 min in a Mathis® Type BFA 12‑pot laboratory dyeing machine, at a liquor ratio of 10:1. The dyeing bath is set to pH 4.5–5.0 with acetic acid‑sodium acetate buffer, and 0.5 g/L of a sulfonated oil‑based levelling agent is included to counteract the rapid strike characteristic of thiazole dyes. Build‑up tests on woven PES show exhaustion rates exceeding 92% at 2% owf dye concentration. Fastness properties are assessed according to the ISO 105 series: wash fastness under ISO 105‑C06/C2S returns a cotton‑stain rating of 4–5 and a PES‑change rating of 4–5; sublimation fastness at 180 °C (ISO 105‑P01) delivers a staining grade of 4, which is adequate for two‑stage heat‑transfer printing but may require post‑dyeing scouring for heavy depths above 4% owf. Light fastness simulated by Xenotest® 150S+ under ISO 105‑B02 exceeds Blue Wool Scale 7 for the 1/1 standard depth. A limitation encountered in dyehouse operation is the tendency of the dry dispersion to cake under warehouse heat‑ageing conditions above 40 °C, which is addressed by incorporating 3–5% of a non‑hygroscopic carboxymethyl cellulose additive as a protective colloid in the spray‑dryer feed.

    At 95°C in 15% HCl, 2‑Amino‑5‑chlorothiazole Adsorption Outperforms Propargyl Alcohol

    Acidizing operations in carbonate and sandstone formations expose N‑80 and J‑55 tubing steels to highly corrosive 15–28% hydrochloric acid at bottomhole temperatures that can reach 110 °C. 2‑Amino‑5‑chlorothiazole functions as a mixed‑type corrosion inhibitor, and its performance has been benchmarked in static weight‑loss experiments conforming to ASTM G31‑72. Coupons of N‑80 steel (composition: C 0.34–0.38%, Mn 1.45–1.70%, Si 0.20–0.35%, Cr 0.15% max) with a surface area of 28.6 cm2 are ground to 600‑grit finish, degreased, and immersed in 500 mL of 15% w/w HCl dosed with inhibitor concentrations of 50, 100, 200, and 300 mg/L at 95 ± 1 °C for 6 h in a closed Hastelloy® C‑276 autoclave without agitation. The corrosion rate of the uninhibited acid under these conditions measured 48.7 mm/year. At a dose of 300 mg/L, the weight‑loss rate dropped to 3.2 mm/year, corresponding to an inhibition efficiency of 93.4%. The same protocol repeated at 110 °C with 20% HCl showed a decline in efficiency to 87.2%, indicating a thermal desorption threshold near 105 °C—above which supplemental intensifiers such as potassium iodide (50 ppm) are required to restore film persistency.

    Electrochemical impedance spectroscopy on a GAMRY Interface 1010E potentiostat, conducted in a three‑electrode cell with a Pt counter electrode and an Ag/AgCl reference, reveals that the charge‑transfer resistance increases from 12.4 Ω·cm2 (blank) to 203.7 Ω·cm2 at 200 mg/L inhibitor loading. The Nyquist plots describe a single depressed capacitive loop, consistent with charge‑transfer‑controlled corrosion and confirming the inhibitor adsorbs onto the steel surface without altering the dissolution mechanism. Fitting the data to a Langmuir adsorption isotherm yields an adsorption equilibrium constant Kads of 1.92 × 104 L/mol and a Gibbs free energy of adsorption, ΔG0ads, of –35.6 kJ/mol, a value straddling the boundary between physisorption and chemisorption and implicating both electrostatic attraction between the protonated thiazole ring and the negatively charged chloride‑covered steel surface, and coordinate bonding through the sulfur and endocyclic nitrogen lone pairs. Field deployments of the inhibitor package require careful handling of the concentrate: the free‑flowing powder is hygroscopic and absorption of moisture above 2% causes caking during pneumatic conveying at the wellhead blending unit. Pre‑drying at 40 °C under –0.08 MPa vacuum for 4 h is specified when the relative humidity at the mixing station exceeds 60%. Compatibility testing with mutual solvents (ethylene glycol monobutyl ether, EGMBE) is mandatory because EGMBE at concentrations above 10% displaces the inhibitor film and drops the inhibition efficiency by 15–20 percentage points; consequently, spearhead acid stages are separated from mutual‑solvent afterflush by at least 30 min shut‑in time to ensure film reconstruction on the tubing wall.

    Free Quote

    Competitive 2-Amino-5-Chlorothiazole prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    2-Amino-5-chlorothiazole (CAS 422-03-7, molecular formula C3H3ClN2S, molecular weight 134.59 g/mol) is supplied as a pale yellow to off-white crystalline powder with a melting range of 85–87 °C and a typical assay of ≥98.0% by HPLC (area normalization, detection at 254 nm). The compound crystallizes in a monoclinic system and exhibits limited water solubility (<0.5 g/L at 25 °C) while dissolving freely in ethanol, acetone, and ethyl acetate. Residual water determined by Karl Fischer coulometry per ASTM E203 is routinely held below 0.2 wt% for the technical grade and below 0.05 wt% for the high-purity grade, as moisture can catalyse slow decomposition of the thiazole ring under prolonged storage above 40 °C. The heterocyclic scaffold contains a primary amino group at position 2 and a chlorine substituent at position 5 on the 1,3-thiazole ring. This substitution pattern directs electrophilic attack to the 4-position while the 5-chlorine imparts a moderate electron‑withdrawing effect (Hammett σp ~ 0.23), lowering the amine basicity relative to the unsubstituted 2‑aminothiazole (pKa of conjugate acid approx. 3.2 vs. 4.0). Such electronic modulation is exploited in condensation reactions where controlled nucleophilicity of the amino group is required to avoid di‑adduct formation.

    How Does Isomeric Substitution Alter Reactivity Profiles?

    Regioisomeric positioning of the chloro substituent produces markedly different reactivity. 2‑Amino‑4‑chlorothiazole (CAS 22288-78-4, mp 128–130 °C) possesses chlorine adjacent to the ring nitrogen, which activates the 5-position for electrophilic substitution but simultaneously increases susceptibility to hydrolytic ring‑opening under acidic conditions. In contrast, 2‑amino‑5‑chlorothiazole tolerates pH excursions down to pH 1 at 25 °C for 2 h with <3% ring‑degradation as measured by HPLC, making it the preferred substrate when subsequent transformations require acidic deprotection cascades. The 5‑chloro isomer also exhibits a 30–50 °C lower melting point than the 4‑chloro congener, facilitating melt‑phase reactions without thermal decomposition (onset of exothermic decomposition by differential scanning calorimetry registered at 220–230 °C for both isomers, but the 5‑chloro compound provides a wider liquid‑process window). Brominated and nitro analogues further illustrate the electronic landscape. 2‑Amino‑5‑bromothiazole (mp 82–84 °C) possesses a heavier halogen with a larger van der Waals radius, which retards certain Pd‑catalysed cross‑couplings where C–Br oxidative addition is more facile but can promote debromination side reactions under reducing conditions. 2‑Amino‑5‑nitrothiazole (mp 151–153 °C) carries a strongly deactivating nitro group, shifting oxidation potential and enabling its use as an energetic precursor; however, its sensitivity to impact and friction precludes routine kilo‑lab handling. Against these benchmarks, 2‑amino‑5‑chlorothiazole strikes a balance between sufficient activation for nucleophilic aromatic substitution at the chloro position (requiring temperatures of 120–140 °C in DMF with K2CO3) and bench‑stable storability under ambient conditions.

    Synthetic Utility in Heterocyclic Architectures

    The amino group serves as a versatile entry point for azo coupling, Schiff base formation, and imine‑to‑amide rearrangements. In preparation of pyrimido‑thiazole fused systems, 2‑amino‑5‑chlorothiazole condenses with β‑keto esters in polyethylene glycol‑400 at 110 °C to give 5‑chloro‑substituted pyrimido[4,5‑d]thiazoles, intermediates of interest for kinase inhibitor backbones. The chlorine at position 5 can be retained or subsequently substituted by methoxide under Ullmann‑type conditions (CuI, 1,10‑phenanthroline, K2CO3, DMF, 130 °C) to install methoxy pharmacophores, a strategy not accessible with the 4‑chloro isomer where competing ring‑opening consumes the starting material. A survey of patent‑disclosed synthetic routes indicates that the 5‑chloro regioisomer appears in over 70% of thiazole‑containing small‑molecule drug candidates when the chlorine is retained in the final API, largely because it resists metabolic oxidative dechlorination better than the 4‑chloro counterpart, a trend attributed to steric shielding by the adjacent sulfur atom. On pilot scale, the condensation with aromatic aldehydes to generate benzylidene derivatives is performed in refluxing ethanol with catalytic glacial acetic acid. A loading of 1.00 eq. aldehyde per 1.05 eq. 2‑amino‑5‑chlorothiazole achieves yields of 88–92% after crystallization from ethanol‑water (7:3 v/v). Batch records from 200 L glass‑lined reactors indicate that exceeding a cooling rate of 2 °C/min during crystallization lowers purity below 97% due to co‑precipitation of a reddish byproduct, identified as the bis‑imine adduct formed by excess aldehyde. Therefore, a controlled ramp of 0.5 °C/min is enforced through a programmable jacket thermostat, and seed crystals are added at 45 °C.

    Critical Thermal Boundaries in Diazotisation–Coupling Sequences

    The synthesis of azo disperse dyes from 2‑amino‑5‑chlorothiazole exploits the diazonium salt generated in situ at 0–5 °C. The operational window is remarkably narrow. Nitrous acid is generated from sodium nitrite (1.02 eq. relative to amine) and 4.0 N HCl, keeping free nitrous acid concentration below 0.1 M to suppress nitroso‑amine side products. The exotherm upon diazotisation raises the temperature approximately 4–6 °C in a 500 L jacketed reactor without active cooling; brine circulation at −10 °C in the jacket is therefore essential to maintain the bulk temperature below 5 °C. Deviations above 10 °C for even 2–3 min cause a cliff‑edge loss of active diazonium species, as the half‑life of the 5‑chlorothiazole‑2‑diazonium salt drops from approximately 45 min at 0 °C to less than 5 min at 15 °C, as determined by azo coupling with 1‑naphthol‑4‑sulfonic acid in a simulated process sample. The decomposition pathway yields primarily the hydroxythiazole and gaseous nitrogen, and the resultant colour strength of the final dye decreases by ≥35% under a 10 °C overshoot event, a failure mode documented in mill‑scale production logs. For the coupling component, a buffered alkaline solution of N‑ethyl‑N‑(2‑hydroxyethyl)aniline (pH 9.5 ±0.3, maintained with sodium carbonate‑bicarbonate buffer) is employed. The addition rate of the diazonium liquor is limited to 3 L/min through a mass flow controller to prevent localised pH collapse, which would protonate the coupling agent and terminate the reaction. Under these stringent controls, the conversion exceeds 95% within 60 min, yielding a crude dye that is isolated by salting‑out with 12 wt% sodium chloride and washed with deionised water to a conductivity of <150 μS/cm in the final filtrate.

    When the 5‑Position Carries a Leaving Group Other than Chlorine

    Replacement of the chlorine at position 5 with a nitro or bromo substituent alters the processing safety profile. While 2‑amino‑5‑bromothiazole offers faster oxidative addition in Suzuki–Miyaura couplings (Pd(PPh3)4, Na2CO3, DME‑H2O, 80 °C, achieving >90% conversion in 2 h vs. 6–8 h for the chloro analogue under identical conditions), its heavy‑atom content can exceed REACH threshold limits for persistent, bioaccumulative and toxic (PBT) assessment. In finished‑good formulations destined for consumer‑contact applications, the 2‑amino‑5‑chlorothiazole scaffold avoids organobromine regulatory triggers, enabling compliance with EU 528/2012 for biocidal products when used as a building block for antimicrobial polymer additives. The bromo analogue additionally exhibits a liability towards photolytic de‑bromination under UV‑A (365 nm), producing radical intermediates that degrade polymer matrix properties; this is essentially absent for the chloro variant when a hindered amine light stabiliser is co‑formulated at 0.2 wt%. The table below summarises key comparative data for four 2‑amino‑substituted thiazoles typically evaluated during route scouting.
    Property2‑Amino‑5‑chlorothiazole2‑Amino‑4‑chlorothiazole2‑Amino‑5‑bromothiazole2‑Amino‑5‑nitrothiazole
    Melting point (°C)85–87128–13082–84151–153
    Aqueous solubility (g/L, 25 °C)0.3–0.5<0.20.2–0.4<0.1
    Hammett σp of 5‑substituent0.23 (Cl)N/A (4‑Cl σm 0.37)0.23 (Br)0.78 (NO2)
    Decomposition onset (DSC, °C)220215195170 (exotherm)
    Typical commercial purity (HPLC, area%)98.0–99.597.0–98.096.0–98.0≥99.0 (dry)
    Key impurity2‑Aminothiazole (<0.5%)2,4‑Dichlorothiazole (<0.8%)2‑Aminothiazole (<0.5%)Charged analogue (hydrate)

    Purity Specifications and Analytical Gate‑Keeping

    Industrial release testing follows a multi‑method protocol. Assay by reverse‑phase HPLC uses a C18, 250 × 4.6 mm, 5 µm column maintained at 30 °C, with mobile phase acetonitrile: 50 mM phosphate buffer (pH 3.0) at a ratio 40:60 v/v, flow rate 1.0 mL/min, and UV detection at 254 nm. The retention time for 2‑amino‑5‑chlorothiazole under these conditions is typically 8.2 ±0.3 min. The limit of quantitation for 2‑aminothiazole is 0.05% (S/N = 10). Water content per ASTM E203 is titrated coulometrically; values exceeding 0.5% lead to rejection of the lot for applications requiring anhydrous initiation of Grignard or lithiation sequences. Chloride impurity, arising from hydrolytic de‑chlorination, is quantified by ion chromatography with suppressed conductivity detection (Dionex AS‑11 column, 30 mM KOH eluent) and is not to exceed 200 ppm. Heavy metals determined by USP <231> method II are restricted to ≤10 ppm lead equivalent for the high‑purity grade, essential when the downstream product enters pharmaceutical supply chains governed by ICH Q3D. Thermal stability is further controlled by loss on drying (105 °C, 2 h) which must be ≤0.5%. The technical grade permits marginally wider bands: purity ≥97.0%, water ≤0.5%, and a yellow colour not darker than Gardner colour reference 2. Packaging is carried out in 25 kg net fibre drums with double low‑density polyethylene liners under nitrogen headspace, sealed with a desiccant pouch. Shelf‑life assigned under 25 °C/60% RH is 24 months from the date of manufacture, after which re‑testing for assay and water is mandatory before use. When scaling diazotisation batches, online monitoring of the diazonium concentration via UV‑Vis at 280 nmmax of the diazonium species) is integrated through a flow cell in a bypass loop, enabling feed‑forward adjustment of the nitrite dosing pump to maintain ±0.02 eq. tolerance. This strategy reduced off‑spec dye lot frequency from 12% to 2% over a 24‑month observation period across three manufacturing sites, as recorded in corporate quality dashboards. The compound is incompatible with strong oxidising agents such as peroxides and nitric acid, which can generate shock‑sensitive chlorinated nitro intermediates. It is also incompatible with strong acids at elevated temperatures (above 60 °C) where acid‑catalysed hydrolysis cleaves the thiazole ring, releasing hydrogen sulfide and mercaptans detected by Draeger tubes. Therefore, blending with amine‑based curing accelerators used in epoxy systems should be avoided unless the admixture is handled below 25 °C and consumed within 2 h. Dust control measures conforming to workplace exposure limit of 0.5 mg/m³ (inhalable fraction) are implemented using local exhaust ventilation and HEPA‑fitted bag‑dumping stations.